Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib.
Pediatr Dermatol
; 2024 Jun 17.
Article
em En
| MEDLINE
| ID: mdl-38886992
ABSTRACT
Giant congenital melanocytic nevi (GCMN) can be cosmetically significant and can lead to melanoma. There is no standard pharmacologic treatment for GCMN. We present the case of an 8-year-old female with kaposiform lymphangiomatosis caused by an NRAS mutation whose nevus spilus-type GCMN improved on oral selumetinib.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article